Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK
Metformin is a first-line drug for the management of type 2 diabetes. Recent studies suggested cardioprotective effects of metformin against ischemia/reperfusion injury. However, it remains elusive whether metformin provides direct protection against hypoxia/reoxygenation (H/R) injury in cardiomyocy...
Main Authors: | Mingyan Hu, Ping Ye, Hua Liao, Manhua Chen, Feiyan Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2016/2961954 |
Similar Items
-
Sevoflurane Postconditioning Attenuates Hypoxia/Reoxygenation Injury of Cardiomyocytes Under High Glucose by Regulating HIF-1α/MIF/AMPK Pathway
by: Haiping Ma, et al.
Published: (2021-02-01) -
RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.
by: Linshan Shang, et al.
Published: (2010-04-01) -
Reactive oxygen and nitrogen species production in cardiomyoblasts during hypoxia and reoxygenation
by: Kolamunne, Rajitha K.
Published: (2010) -
Changes of mitochondrial pathway in hypoxia/reoxygenation induced cardiomyocytes apoptosis.
by: Tielong Chen, et al.
Published: (2008-01-01) -
Ginsenoside Rg1 Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury via Activation of Nrf2/HO-1 Signaling and Inhibition of JNK
by: Qianhui Li, et al.
Published: (2017-11-01)